LIFECORE BIOMEDICAL INC DE
For the period ended May 25, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Aug 7, 2025
LFCR$6.370.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal accountant fees and services
Information with respect to this item is incorporated by reference to the 2025 Proxy Statement under the headings “Fees Paid to Independent Registered Accounting Public Accounting Firm” and “Audit Committee Pre-Approval Policies.”
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.